The Delhi High Court on Tuesday expressed displeasure over "huge wastage" of vaccines and asked the Centre to vaccinate whomsoever it can to ensure there is no wastage.
A bench of Justices Vipin Sanghi and Rekha Palli said according to news reports there is a daily wastage of six per cent of vaccines and till now 44 lakh vaccines out of 10 crore have been wasted, maximum in Tamil Nadu.
"This is a huge wastage. Give it to those who want it.
Whomsoever you can vaccinate, please vaccinate. Whether 16 year old or 60 year old, all need vaccination. The pandemic does not discriminate," the court told the Centre.
The court said young people are being affected more this time round, and lot of young lives have been lost.
It said if at the end of a day, a few shots are available in a vial, then it be given to someone whether they fall in the approved categories for vaccination or not.
The observations by the bench came during the hearing of a disposed of petition related to COVID-19 tests which was revived on April 19 (Monday).
The high court Monday noted that the virus has raised its "ugly head" once again and the pandemic is raging with much greater intensity and "it is evident that the healthcare infrastructure is at the stage of imminent collapse".
The Delhi High Court also expressed hope that the Central government was allocating or diverting resources and medicines, like Remdesivir, based on the needs and situation of each state, otherwise "people will have blood on their hands". "We will be doomed," the bench said with regard to any non-application of mind in allocation and diversion of resources and medicines. Additional Solicitor General (ASG) Chetan Sharma and central government standing counsel Moniika Arora told the court that medical opinion was divided on use of Remdesivir. Senior advocate Rahul Mehra, appearing for the Delhi government, told the court that doctors were prescribing Remdesivir and people are unable to get it from the market despite having prescriptions. "Long and short of it is that it (Remdesivir) is in short supply," the bench said and added that giving clearance for setting up units to manufacture would not yield quick results as establishing the facilities for manufacture takes time. The observations by the bench came during the hearing of a disposed of petition related to COVID-19 tests and the high court revived it on April 19 by noting that the virus has raised its "ugly head" once again and the pandemic is raging with much greater intensity and "it is evident that the healthcare infrastructure is at the stage of imminent collapse".
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU